Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
21,926,927
-
Total 13F shares
-
3,764,070
-
Share change
-
+3,757,995
-
Total reported value
-
$183,385,609
-
Put/Call ratio
-
20%
-
Price per share
-
$48.72
-
Number of holders
-
36
-
Value change
-
+$183,089,636
-
Number of buys
-
35
Institutional Holders of Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR) as of Q3 2025
As of 30 Sep 2025,
Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,764,070 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., VR ADVISER, LLC, FCPM III SERVICES B.V., FMR LLC, Ariose Capital Management Ltd, VANGUARD GROUP INC, UBS Group AG, JOHNSON & JOHNSON, TANG CAPITAL MANAGEMENT LLC, and BlackRock, Inc..
This page lists
36
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.